Taylor Wessing advises The Rohatyn Group on investment in Optimapharm d.d.

International law firm Taylor Wessing has advised The Rohatyn Group on its investment in Optimapharm d.d. (Optimapharm), a contract research organisation headquartered in Croatia, with 14 offices across Europe, including a heavy presence in CEE. The investment establishes a partnership with the company’s founders Gordana Gregurić Čičak and Igor Čičak. 

Optimapharm organises and manages clinical trials for US and Western European pharmaceutical companies, biotech players and medical device companies. With the investment, Optimapharm will seek to continue to grow both organically and through strategic acquisitions.

The multijurisdictional deal required input from a number of foreign counsels focusing predominantly on Austria, Croatia, Czech Republic, Serbia and Switzerland.

The deal required expertise drawn from across the firm's private equity, banking and finance and tax teams.

Read the full story



Read more

Looking for something specific?